Skip to content

OKYO Pharma Ltd

OKYO · XNAS

CIK 1849296fmd_0P4TCJPDPHG0A28MWCNG7ZX42PManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Apr 01, 2019 to Mar 31, 2026, 7 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written
0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).

Loading